Agents to inhibit the increase in intraneuronal calcium concentration
DE602019068134T2Active Publication Date: 2025-04-02TORAY INDUSTRIES INC
0 Cites 0 Cited by
Patent Information
- Application Number
- DE602019068134
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2019-03-29
- Publication Date
- 2025-04-02
- Estimated Expiration
- 2039-03-29
AI Technical Summary
Technical Problem
Existing agents do not effectively inhibit abnormal rises in intraneuronal calcium concentration, which can lead to various nervous diseases and disorders associated with neuronal hyperexcitability.
Method used
A cyclic amine derivative or its pharmacologically acceptable salt, represented by specific structural formulas, is developed to inhibit the rise in intraneuronal calcium concentration, targeting diseases such as Alzheimer's, Parkinson's, epilepsy, and other neurological conditions.
Benefits of technology
The cyclic amine derivative significantly inhibits intraneuronal calcium concentration, providing therapeutic benefits for neuronal hyperexcitability-related disorders by maintaining normal calcium levels within neurons.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.